Governance approval should be much faster this time than the EMD AML trial as the first site is private, not public. Recruitment should be easier as we are not looking to recruit patient with a subtype of an orphan disease, but saying this recruitment for all clinical trials is hard these days.
RAC Price at posting:
$1.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)